Lv66
1680 积分 2025-04-23 加入
A novel TNFR2 agonist antibody expands highly potent regulatory T cells
2个月前
已完结
GenSci120, a humanized PD-1 agonistic monoclonal antibody, enhances the binding of both PD-L1 and PD-L2 to PD-1, and mitigates the symptoms of GVHD in a mouse model
3个月前
已完结
LUNA18, a macrocyclic orally bioavailable peptide pan-RAS inhibitor, discovered from a beyond rule of 5 drug discovery platform
4个月前
已完结
LUNA18, a macrocyclic orally bioavailable peptide pan-RAS inhibitor, discovered from a beyond rule of 5 drug discovery platform
4个月前
已关闭
LUNA18, a macrocyclic orally bioavailable peptide pan-RAS inhibitor, discovered from a beyond rule of 5 drug discovery platform
4个月前
已关闭
Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy
4个月前
已完结
Valence and avidity determine the agonistic activity of anti-TNFR2 nanobody fusion proteins
4个月前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
7个月前
已完结
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models
8个月前
已完结
Efficacy and safety profile of avelumab monotherapy
10个月前
已完结
皖公网安备34019202002308
